News
News
News
Latest news
Tanya Richardson, Fortrea
Executive Director, Strategic, Delivery & Growth, Ophthalmology and Neuroscience Lead
Dr. David Eichenbaum, MD, Retina Vitreous Associates of Florida
Director of Research
Dr. Mark Packer, MD, Packer Research Association
President
Brian Guthrie, Fortrea
Director, Strategic Delivery & Growth
Ben Toker, Amaros
President and Co-Founder
Tanya Richardson, Fortrea
Executive Director, Strategic, Delivery & Growth, Ophthalmology and Neuroscience Lead
Dr. David Eichenbaum, MD, Retina Vitreous Associates of Florida
Director of Research
Dr. Mark Packer, MD, Packer Research Association
President
Brian Guthrie, Fortrea
Director, Strategic Delivery & Growth
Ben Toker, Amaros
President and Co-Founder
Tanya Richardson, Fortrea
Executive Director, Strategic, Delivery & Growth, Ophthalmology and Neuroscience Lead
Dr. David Eichenbaum, MD, Retina Vitreous Associates of Florida
Director of Research
Dr. Mark Packer, MD, Packer Research Association
President
Brian Guthrie, Fortrea
Director, Strategic Delivery & Growth
Ben Toker, Amaros
President and Co-Founder
Precision Intelligence for Ophthmalogy
© 2026 Amaros, Inc. All rights reserved.
Precision Intelligence for Ophthmalogy
© 2026 Amaros, Inc. All rights reserved.
Precision Intelligence for Ophthmalogy
© 2026 Amaros, Inc. All rights reserved.
Precision Intelligence for Ophthmalogy
© 2026 Amaros, Inc. All rights reserved.
Advance ophthalmology with our innovative solutions.
• Accelerates enrollment and enhances protocol execution for CROs and trial teams.
• Enables personalized, precision care at the point of service.
• Reveals access gaps and growth opportunities for clinics and healthcare companies.
Advance ophthalmology with our innovative solutions.
• Accelerates enrollment and enhances protocol execution for CROs and trial teams.
• Enables personalized, precision care at the point of service.
• Reveals access gaps and growth opportunities for clinics and healthcare companies.
Advance ophthalmology with our innovative solutions.
• Accelerates enrollment and enhances protocol execution for CROs and trial teams.
• Enables personalized, precision care at the point of service.
• Reveals access gaps and growth opportunities for clinics and healthcare companies.